Loss of MGMT expression, associated with methylation of its promoter, defines a subset of HCCs [80] and has been reported in tumour‐adjacent tissue from HCC patients; however, this loss of expression was without associated promoter hypermethylation as measured using methylation‐specific PCR [82]. This evidence concerns the gene MGMT and hepatocellular carcinoma.